(Hypertension. 1999;33:366-372.)
© 1999 American Heart Association, Inc.
Scientific Contributions |
From the Medical Research Council Multidisciplinary Research Group on Hypertension, Clinical Research Institute of Montreal and Université de Montréal, Montreal, Quebec, Canada.
Correspondence to Rhian M. Touyz, MD, PhD, Clinical Research Institute of Montreal, 110 Pine Ave W, Montreal (Quebec), Canada H2W 1R7. E-mail touyz{at}ircm.umontreal.ca
AbstractThis study assesses the
receptor subtype (AT1 and AT2) through which
angiotensin II (Ang II) mediates contraction in small
arteries of young and adult spontaneously hypertensive rats (SHR).
Segments of third-order mesenteric arteries (
200 µm in lumen
diameter) were mounted in a pressurized system. Systolic blood
pressure and media:lumen ratio of small arteries were significantly
greater (P<0.001) in young SHR and adult SHR than in
age-matched Wistar-Kyoto rats (WKY). Ang IIinduced contractile
effects were significantly increased (P<0.05) in young
SHR compared with age-matched WKY. AT1 blockade with
losartan, and combined AT1 and AT2
blockade with losartan and PD123319, abolished Ang
IIstimulated contraction in young and adult rats. AT2
blockade (PD123319) significantly reduced (P<0.01) Ang
IIelicited contraction in young SHR but had no effect in WKY or adult
SHR, indicating that AT2 receptors may contribute to Ang
IIinduced contraction in young SHR. To determine the Ang receptor
status in rat mesenteric vessels, AT1 and AT2
receptor mRNA expression was determined by reverse
transcriptionpolymerase chain reaction. AT1 and
AT2 receptor protein expression were detected by Western
blot analysis. AT1 receptor mRNA was equally
expressed in age-matched rats, but expression was significantly lower
in young rats compared with adult rats. AT2 receptor mRNA
was weakly expressed in WKY and adult SHR. In vessels from young SHR,
AT2 receptor mRNA expression was significantly increased
compared with the other groups. AT1 receptor protein was
equally expressed in adult rats of both strains but was undetectable in
young rats. AT2 receptor protein was only detectable in
young rats, with the magnitude of expression greater in SHR than WKY.
In conclusion, Ang IIstimulated contractile responses are augmented
in vessels from young SHR. These effects are reduced by selective
AT2 blockade and abolished by AT1 blockade,
indicating that both Ang receptor subtypes are involved in contraction
in young SHR. In WKY and adult SHR, losartan, but not PD123319,
inhibited Ang IIinduced contraction, indicating the exclusive
involvement of AT1 receptors. Thus, in SHR, in the phase of
developing hypertension, enhanced Ang IIstimulated vascular
contraction may be associated with changes in Ang II receptor status,
as evidenced pharmacologically and by increased vascular
AT2 receptor mRNA and protein expression.
Key Words: resistance arteries hypertension receptors, angiotensin vasoconstriction PD123319 losartan
This article has been cited by other articles:
![]() |
D. Xiao, X. Huang, Z. Xu, S. Yang, and L. Zhang Prenatal Cocaine Exposure Differentially Causes Vascular Dysfunction in Adult Offspring Hypertension, June 1, 2009; 53(6): 937 - 943. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Padia, B. A. Kemp, N. L. Howell, J. J. Gildea, S. R. Keller, and R. M. Carey Intrarenal Angiotensin III Infusion Induces Natriuresis and Angiotensin Type 2 Receptor Translocation in Wistar-Kyoto but not in Spontaneously Hypertensive Rats Hypertension, February 1, 2009; 53(2): 338 - 343. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Liu, D. Yang, H. He, X. Chen, T. Cao, X. Feng, L. Ma, Z. Luo, L. Wang, Z. Yan, et al. Increased Transient Receptor Potential Canonical Type 3 Channels in Vasculature From Hypertensive Rats Hypertension, January 1, 2009; 53(1): 70 - 76. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Lee, S. Xia, and L. Ragolia Upregulation of AT2 receptor and iNOS impairs angiotensin II-induced contraction without endothelium influence in young normotensive diabetic rats Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2008; 295(1): R144 - R154. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Xiao, Z. Xu, X. Huang, L. D. Longo, S. Yang, and L. Zhang Prenatal Gender-Related Nicotine Exposure Increases Blood Pressure Response to Angiotensin II in Adult Offspring Hypertension, April 1, 2008; 51(4): 1239 - 1247. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Macarthur, T. C. Westfall, and G. H. Wilken Oxidative stress attenuates NO-induced modulation of sympathetic neurotransmission in the mesenteric arterial bed of spontaneously hypertensive rats Am J Physiol Heart Circ Physiol, January 1, 2008; 294(1): H183 - H189. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wang, J. Zhang, L.-Q. Jiang, G. Spinetti, G. Pintus, R. Monticone, F. D. Kolodgie, R. Virmani, and E. G. Lakatta Proinflammatory Profile Within the Grossly Normal Aged Human Aortic Wall Hypertension, July 1, 2007; 50(1): 219 - 227. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wang, D. Zhao, G. Spinetti, J. Zhang, L.-Q. Jiang, G. Pintus, R. Monticone, and E. G. Lakatta Matrix Metalloproteinase 2 Activation of Transforming Growth Factor-{beta}1 (TGF-{beta}1) and TGF-{beta}1-Type II Receptor Signaling Within the Aged Arterial Wall Arterioscler Thromb Vasc Biol, July 1, 2006; 26(7): 1503 - 1509. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wang, J. Zhang, G. Spinetti, L.-Q. Jiang, R. Monticone, D. Zhao, L. Cheng, M. Krawczyk, M. Talan, G. Pintus, et al. Angiotensin II Activates Matrix Metalloproteinase Type II and Mimics Age-Associated Carotid Arterial Remodeling in Young Rats Am. J. Pathol., November 1, 2005; 167(5): 1429 - 1442. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Brassard, F. Amiri, and E. L. Schiffrin Combined Angiotensin II Type 1 and Type 2 Receptor Blockade on Vascular Remodeling and Matrix Metalloproteinases in Resistance Arteries Hypertension, September 1, 2005; 46(3): 598 - 606. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Guimaraes and H. Pinheiro Functional evidence that in the cardiovascular system AT1 angiotensin II receptors are AT1B prejunctionally and AT1A postjunctionally Cardiovasc Res, August 1, 2005; 67(2): 208 - 215. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gonzalez, L. Lobos, F. Castillo, L. Galleguillos, N. C. Lopez, and L. Michea High-Salt Diet Inhibits Expression of Angiotensin Type 2 Receptor in Resistance Arteries Hypertension, May 1, 2005; 45(5): 853 - 859. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. You, L. Loufrani, C. Baron, B. I. Levy, R. E. Widdop, and D. Henrion High Blood Pressure Reduction Reverses Angiotensin II Type 2 Receptor-Mediated Vasoconstriction Into Vasodilation in Spontaneously Hypertensive Rats Circulation, March 1, 2005; 111(8): 1006 - 1011. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Vazquez, I. Coronel, R. Bautista, E. Romo, C. M. Villalon, M. C. Avila-Casado, V. Soto, and B. Escalante Angiotensin II-dependent induction of AT2 receptor expression after renal ablation Am J Physiol Renal Physiol, January 1, 2005; 288(1): F207 - F213. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yayama, M. Horii, H. Hiyoshi, M. Takano, H. Okamoto, S. Kagota, and M. Kunitomo Up-Regulation of Angiotensin II Type 2 Receptor in Rat Thoracic Aorta by Pressure-Overload J. Pharmacol. Exp. Ther., February 1, 2004; 308(2): 736 - 743. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. I. Levy Can Angiotensin II Type 2 Receptors Have Deleterious Effects in Cardiovascular Disease?: Implications for Therapeutic Blockade of the Renin-Angiotensin System Circulation, January 6, 2004; 109(1): 8 - 13. [Full Text] [PDF] |
||||
![]() |
L. M. Duke, G. A. Eppel, R. E. Widdop, and R. G. Evans Disparate Roles of AT2 Receptors in the Renal Cortical and Medullary Circulations of Anesthetized Rabbits Hypertension, August 1, 2003; 42(2): 200 - 205. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wang, G. Takagi, K. Asai, R. G. Resuello, F. F. Natividad, D. E. Vatner, S. F. Vatner, and E. G. Lakatta Aging Increases Aortic MMP-2 Activity and Angiotensin II in Nonhuman Primates Hypertension, June 1, 2003; 41(6): 1308 - 1316. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. S. Gragasin, Y. Xu, I. A. Arenas, N. Kainth, and S. T. Davidge Estrogen Reduces Angiotensin II-Induced Nitric Oxide Synthase and NAD(P)H Oxidase Expression in Endothelial Cells Arterioscler Thromb Vasc Biol, January 1, 2003; 23(1): 38 - 44. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Pantev, E. Stenman, A. Wackenfors, L. Edvinsson, and M. Malmsjo Comparison of the antagonistic effects of different angiotensin II receptor blockers in human coronary arteries Eur J Heart Fail, December 1, 2002; 4(6): 699 - 705. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Widdop, K. Matrougui, B. I. Levy, and D. Henrion AT2 Receptor-Mediated Relaxation Is Preserved After Long-Term AT1 Receptor Blockade Hypertension, October 1, 2002; 40(4): 516 - 520. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Touyz, X. Chen, F. Tabet, G. Yao, G. He, M. T. Quinn, P. J. Pagano, and E. L. Schiffrin Expression of a Functionally Active gp91phox-Containing Neutrophil-Type NAD(P)H Oxidase in Smooth Muscle Cells From Human Resistance Arteries: Regulation by Angiotensin II Circ. Res., June 14, 2002; 90(11): 1205 - 1213. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Berry, R. Touyz, A. F. Dominiczak, R. C. Webb, and D. G. Johns Angiotensin receptors: signaling, vascular pathophysiology, and interactions with ceramide Am J Physiol Heart Circ Physiol, December 1, 2001; 281(6): H2337 - H2365. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Carey, N. L. Howell, X.-H. Jin, and H. M. Siragy Angiotensin Type 2 Receptor-Mediated Hypotension in Angiotensin Type-1 Receptor-Blocked Rats Hypertension, December 1, 2001; 38(6): 1272 - 1277. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Zhang, M.-H. Wang, U.M. Krishna, J. R. Falck, M. Laniado-Schwartzman, and A. Nasjletti Modulation by 20-HETE of Phenylephrine-Induced Mesenteric Artery Contraction in Spontaneously Hypertensive and Wistar-Kyoto Rats Hypertension, December 1, 2001; 38(6): 1311 - 1315. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Henrion, N. Kubis, and B. I. Levy Physiological and Pathophysiological Functions of the AT2 Subtype Receptor of Angiotensin II: From Large Arteries to the Microcirculation Hypertension, November 1, 2001; 38(5): 1150 - 1157. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Bautista, A. Sanchez, J. Hernandez, A. Oyekan, and B. Escalante Angiotensin II Type AT2 Receptor mRNA Expression and Renal Vasodilatation Are Increased in Renal Failure Hypertension, September 1, 2001; 38(3): 669 - 673. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Shastri, J. R. McNeill, T. W. Wilson, R. Poduri, C. Kaul, and V. Gopalakrishnan Cysteinyl leukotrienes mediate enhanced vasoconstriction to angiotensin II but not endothelin-1 in SHR Am J Physiol Heart Circ Physiol, July 1, 2001; 281(1): H342 - H349. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Touyz, G. He, X.-H. Wu, J. B. Park, M. E. Mabrouk, and E. L. Schiffrin Src Is an Important Mediator of Extracellular Signal-Regulated Kinase 1/2-Dependent Growth Signaling by Angiotensin II in Smooth Muscle Cells From Resistance Arteries of Hypertensive Patients Hypertension, July 1, 2001; 38(1): 56 - 64. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. F. Moore, N. T. Heiderstadt, E. Huang, N. L. Howell, Z.-Q. Wang, H. M. Siragy, and R. M. Carey Selective Inhibition of the Renal Angiotensin Type 2 Receptor Increases Blood Pressure in Conscious Rats Hypertension, May 1, 2001; 37(5): 1285 - 1291. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Touyz, G. He, M. El Mabrouk, and E. L. Schiffrin p38 MAP Kinase Regulates Vascular Smooth Muscle Cell Collagen Synthesis by Angiotensin II in SHR But Not in WKY Hypertension, February 1, 2001; 37(2): 574 - 580. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Stanke-Labesque, P. Devillier, S. Veitl, F. Caron, J.-L. Cracowski, and G. Bessard Cysteinyl leukotrienes are involved in angiotensin II-induced contraction of aorta from spontaneously hypertensive rats Cardiovasc Res, January 1, 2001; 49(1): 152 - 160. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Touyz and E. L. Schiffrin Signal Transduction Mechanisms Mediating the Physiological and Pathophysiological Actions of Angiotensin II in Vascular Smooth Muscle Cells Pharmacol. Rev., December 1, 2000; 52(4): 639 - 672. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. E. Schutzer, H. Xue, J. F. Reed, J.-B. Roullet, S. Anderson, and S. L. Mader Angiotensin II enhances beta -adrenergic receptor-mediated vasorelaxation in aortas from young but not old rats Am J Physiol Heart Circ Physiol, December 1, 2000; 279(6): H2807 - H2814. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.-S. Tea, S. Der Sarkissian, R. M. Touyz, P. Hamet, and D. deBlois Proapoptotic and Growth-Inhibitory Role of Angiotensin II Type 2 Receptor in Vascular Smooth Muscle Cells of Spontaneously Hypertensive Rats In Vivo Hypertension, May 1, 2000; 35(5): 1069 - 1073. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gallinat, S. Busche, M. K. Raizada, and C. Sumners The angiotensin II type 2 receptor: an enigma with multiple variations Am J Physiol Endocrinol Metab, March 1, 2000; 278(3): E357 - E374. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. RUAN, M. I. OLIVERIO, T. M. COFFMAN, and W. J. ARENDSHORST Renal Vascular Reactivity in Mice: AngII-Induced Vasoconstriction inAT1A Receptor Null Mice J. Am. Soc. Nephrol., December 1, 1999; 10(12): 2620 - 2630. [Abstract] [Full Text] |
||||
![]() |
Q. N. Diep, J.-S. Li, and E. L. Schiffrin In Vivo Study of AT1 and AT2 Angiotensin Receptors in Apoptosis in Rat Blood Vessels Hypertension, October 1, 1999; 34(4): 617 - 624. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Matrougui, L. Loufrani, C. Heymes, B. I. Levy, and D. Henrion Activation of AT2 Receptors by Endogenous Angiotensin II Is Involved in Flow-Induced Dilation in Rat Resistance Arteries Hypertension, October 1, 1999; 34(4): 659 - 665. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Pieber, G. Horina, A. Sandner-Kiesling, T. R. Pieber, and A. Heinemann Pressor and mesenteric arterial hyporesponsiveness to angiotensin II is an early event in haemorrhagic hypotension in anaesthetised rats Cardiovasc Res, October 1, 1999; 44(1): 166 - 175. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |